UROPASS-D

Tamsulosin & Dutasteride

UROGENITAL » ALPHA BLOCKER & 5α REDUCTASE INHIBITOR

INDICATION

Uropass-D is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate.

DOSAGE AND ADMINISTRATION

The recommended dose of Uropass-D is one capsule once daily approximately 30 minutes after the same meal each day. This capsule should be swallowed whole with water.

OR, AS DIRECTED BY PHYSICIAN.

COMPOSITION

Each capsule contains Tamsulosin Hydrochloride sustained-release & Dutasteride immediate release blended pellets pharma grade equivalent to Tamsulosin Hydrochloride USP 0.4 mg & Dutasteride INN 0.5 mg.